Aclaris Therapeutics Inc

NASDAQ: ACRS
$1.19
+$0.00 (+0.0%)
Closing price May 20, 2024

ACRS Chart and Intraday Price

ACRS Company Data

Asset Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address SUITE 400, 101 LINDENWOOD DRIVE, MALVERN, PA, US
Fiscal Year End December
Latest Quarter 2023-12-31
Market Cap 88.30M USD
Shares Outstanding 70,925,000
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a line of novel small molecule therapeutics to address the needs of patients with immuno-inflammatory diseases. The company is headquartered in Wayne, Pennsylvania.

ACRS Articles

Tuesday’s top analyst upgrades and downgrades included Campbell Soup, Exact Sciences, Exelixis, Pool, Spirit Airlines and ZTO Express.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including BP, Conagra Brands, Mattel, Norwegian Cruise Line, PepsiCo and UnitedHealth.
Aclaris shares more than doubled to start out the week after the company announced positive results from its mid-stage rheumatoid arthritis study.